Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for judging benignancy and malignancy of pulmonary nodules by blood sample

A technology for blood samples and pulmonary nodules, applied in the fields of genetic testing, bioinformatics, and mathematical modeling, can solve problems such as relatively large accuracy fluctuations, and achieve the effects of avoiding missed detection, high sensitivity, and avoiding experience errors.

Inactive Publication Date: 2018-12-07
SHENZHEN HAPLOX BIOTECH
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the limitation of doctors' experience, the accuracy of this method fluctuates greatly, and there are a lot of over-detection and missed detection.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for judging benignancy and malignancy of pulmonary nodules by blood sample

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] to combine figure 1 As shown, a method for judging benign and malignant pulmonary nodules through blood samples is judged by using cfDNA polygenic variation combined with machine learning, including the following steps:

[0027] 1. Treat the peripheral blood of 84 patients with pulmonary nodules (48 malignant and 36 benign) and extract the free DNA in the peripheral blood plasma. The cfDNA content in the peripheral blood of cfDNA extraction is very low, so the plasma cfDNA extraction is guaranteed Quality matters. The detailed steps of the cfDNA extraction protocol are as follows: For the extraction and purification of cfDNA from peripheral blood, 10 mL of whole blood is usually used, and the plasma is separated within 3 hours after the blood is obtained. Centrifuge at 16000g for 10min at 4°C, collect the supernatant plasma and transfer it to a 5mL centrifuge tube. It is best to extract DNA immediately from the separated plasma to ensure the integrity of the DNA in th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for judging benignancy and malignancy of pulmonary nodules by a blood sample. Determination is performed through combination of cfDNA polygene variation and machine learning. The method includes the following steps: performing library construction on peripheral blood cfDNA of a pulmonary nodule patient; performing hybrid capture on the cfDNA by utilizing 18 gene capture probes related to a lung cancer; and performing sequencing by utilizing a sequencer, analyzing the cumulative mutation frequency of each of genes, and judging the benignancy and the malignancy of samples by utilizing a logistic regression model. The method can distinguish the benignancy and the malignancy of the pulmonary nodule patient with high sensitivity and high specificity, avoids experience errors of artificial reading CT imaging, and avoids missing detection of a lung cancer and pain of puncture or surgical sampling biopsy of a benign nodule patient.

Description

technical field [0001] The invention relates to the fields of gene detection, bioinformatics, mathematical modeling and the like, and in particular to a method for judging benign and malignant pulmonary nodules through blood samples. Background technique [0002] Lung cancer is a disease that seriously endangers human health. According to the data released by WHO, lung cancer ranks first in the world in terms of incidence and mortality. Recently, the China Cancer Center announced that the annual incidence of cancer in China is 4,291,600 (2,512,100 males, 1,779,500 females), of which the annual incidence of lung cancer is 733,300 (509,300 males, 224,000 females), and the annual death rate The number of cases was 610,200 (432,400 males and 177,800 females), ranking first among tumors in China (Chen et al., 2016). In addition, due to late diagnosis, the 5-year survival rate of lung cancer in my country is only 15.6%. To improve the prognosis of lung cancer, there is also an u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/156
Inventor 温媛周衍庆陈实富张实唯
Owner SHENZHEN HAPLOX BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com